Diabetes, COVID 19 and mucormycosis

Abstract

Aim Patients with diabetes mellitus are more likely to develop invasive fungal infections. Mucormycosis with COVID 19 infection has recently increased, especially in diabetic patients. The goal of this investigation is to examine the clinical range of COVID-associated Mucormycosis with diabetes and subsequent results. Materials and methods This study includes 59 cases in Al-Mujtahid Hospital, and this study is a Cohort study. Results The sample included 59 patients with Mucormycosis, their average age was 58.9 years with a standard deviation of 12.2 years, where the number of patients with diabetes was 56 patients with a percentage of 95%, while the patients with high blood pressure were 25 patients with a percentage of 42%, and 46 patients suffered from covid-19 with a percentage of 78%. In addition to the previous diseases, the patients suffered from many symptoms, including: Nerve injuries, Nerves 2-3-4-5-6-7 were injured with a percentage of 33%, and Nerves 2-3-4-5-6 came in second place by 22%, and 24% of patients reported black crusts in the nasal cavity, 12% suffered from necrosis of the roof of the palate, and the most affected sinus was the ethmoid sinus in 61%, followed by the maxillary sinus with 58% and the frontal and sphenoid sinus 56%. By following up on these patients, 27 patients died and only 3 patients healed. In terms of hospital discharge, 24 patients were discharged, and the rest were discharged under their responsibility. Conclusion Diabetes should be controlled in all patients with Mucormycosis, and periodic examinations should be carried out for diabetic patients, and future studies should be conducted to understand the relationship between diabetes and Mucormycosis.